Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
105,670,220
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
16,255,471
-
Shares change
-
+16,255,471
-
Total reported value, excl. options
-
$250,516,107
-
Value change
-
+$250,516,106
-
Number of buys
-
55
-
Price
-
$15.44
Significant Holders of Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) as of Q1 2018
55 filings reported holding RCUS - Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q1 2018.
Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16,255,471 shares
of 105,670,220 outstanding shares and own 15% of the company stock.
Largest 10 shareholders include Alphabet Inc. (5,049,786 shares), EcoR1 Capital, LLC (2,236,387 shares), WELLINGTON MANAGEMENT GROUP LLP (2,116,945 shares), BVF INC/IL (1,269,788 shares), Partner Fund Management, L.P. (933,286 shares), PRICE T ROWE ASSOCIATES INC /MD/ (655,438 shares), Foresite Capital Management IV, LLC (650,000 shares), Board of Trustees of The Leland Stanford Junior University (625,062 shares), JANUS HENDERSON GROUP PLC (468,587 shares), and Hillhouse Capital Management, Ltd. (425,000 shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.